Investigation of GPM6B as a novel therapeutic target in Osteoarthritis
Arthritis Research & Therapy · 2024
DOI: 10.1186/s13075-024-03430-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Research & Therapy, 2024. Verfasst von Chongyang Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedic Department of Tangdu Hospital, Fourth Military Medical University, Shaanxi, Xi'an, 710038, China. Hauptthemen laut MEDLINE: Osteoarthritis, Mice, Knockout. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Osteoarthritis (OA) is the most common motor system disease in older people, characterized by a high incidence and significant social and economic burden. Women have a higher risk of OA, more severe clinical symptoms, and a higher rate of disabilities than men. However, the pathogenesis of OA remains unclear. Therefore, we screened for differentially expressed genes (DEGs) in OA patients of different sex and searched for new targets that may be involved in regulating the development of OA. METHODS: The study compared the expression of DEGs in synovial fluid exosomes between male and female patients with OA through RNA sequencing combined with bioinformatics analysis using public data. To evaluate the screened DEGs, synovial tissue and fluid samples were obtained from patients with OA who underwent joint replacement surgery. SiRNA-mediated knockdown in vitro experiments were performed to investigate the role of glycoprotein membrane 6B (GPM6B). Meanwhile, GPM6B gene knockout mice were used to assess the in vivo pathological roles of GPM6B in OA. RESULTS: The results revealed that GPM6B is a potential target associated with OA. Immunofluorescence staining demonstrated that GPM6B was expressed in fibroblast-like synoviocytes (FLS) and macrophage-like synoviocytes in patients with OA. In vitro experiments confirmed that GPM6B knockdown can reduce the expression of inflammatory factors in primary FLS from patients with OA. Under inflammatory conditions, GPM6B knockdown can reduce the expression of matrix metalloproteinases as well as proliferation of FLS. In addition, using a destabilization of the medial meniscus-induced OA model, we revealed that GPM6B is associated with OA progression in mice. CONCLUSION: Thus, we provided evidence that GPM6B act as a new target associated with OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Orthopedic Department of Tangdu Hospital, Fourth Military Medical University, Shaanxi, Xi'an, 710038, China.
- Department of Emergency, Honghui Hospital, Xi'an Jiaotong University, Shaanxi, Xi'an, 710054, China.
- Knee Preservation Division, Joint Surgery Department, Honghui Hospital, Xi'an Jiaotong University, Shaanxi, Xi'an, 710054, China.
- Knee Preservation Division, Joint Surgery Department, Honghui Hospital, Xi'an Jiaotong University, Shaanxi, Xi'an, 710054, China. beijun2@sina.com.
Zitieren
APA
Feng, C., Liu, L., Zhang, J., Wang, L., Lv, K., Li, H., & Ding, Y. (2024). Investigation of GPM6B as a novel therapeutic target in Osteoarthritis. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-024-03430-6
Vancouver
Feng C, Liu L, Zhang J, Wang L, Lv K, Li H, et al. Investigation of GPM6B as a novel therapeutic target in Osteoarthritis. Arthritis Research & Therapy. 2024. doi:10.1186/s13075-024-03430-6
BibTeX
@article{Feng2024,
author = {Feng, Chongyang and Liu, Lin and Zhang, Jinxue and Wang, Linxiao and Lv, Ke and Li, Hongbo and Ding, Yong},
title = {Investigation of GPM6B as a novel therapeutic target in Osteoarthritis},
journal = {Arthritis Research & Therapy},
year = {2024},
doi = {10.1186/s13075-024-03430-6}
}
EUVIMED